2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.125

Change

-0.04 (-0.58)%

Market Cap

USD 0.52B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.49% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.49% 55% F 56% F
Trailing 12 Months  
Capital Gain 13.81% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.81% 62% D 60% D-
Trailing 5 Years  
Capital Gain 43.75% 66% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.75% 66% D+ 54% F
Average Annual (5 Year Horizon)  
Capital Gain 5.86% 64% D 63% D
Dividend Return 5.86% 62% D 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.10% 45% F 76% C+
Risk Adjusted Return 41.59% 59% D- 66% D+
Market Capitalization 0.52B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.